首页 > 市场调查报告书 > 製药

疼痛

市场调查报告书

商品编码

1461327

全球非鸦片类疼痛治疗市场，依药物类型、适应症、给药配销通路、通路、地理位置

Global Non Opioid Pain Treatment Market, By Drug Type, By Indication, By Route of Administration, By Distribution Channel, By Geography

出版日期: 2024年03月11日 | 出版商:

Coherent Market Insights | 英文 164 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计2024年全球非鸦片类疼痛治疗市场价值为788.9亿美元，预计到2031年将达到1405.6亿美元，2024年至2031年年复合成长率(CAGR)为8.6%。

报告范围		报告详情
基准年：	2023年	2023/2024 年市场规模：	788.9 亿美元
历史数据：	2019年至2023年	预测期：	2024年至2031年
预测期间 2023/2024 至 2030/2031 年复合成长率：	8.60%	2030/2031 价值预测：	1405.6 亿美元

全球非鸦片类疼痛治疗市场占有率 (%)（按地区），2024 年

慢性疼痛疾病盛行率的上升以及对开发更安全的鸦片类镇痛药替代品的关注正在推动全球非鸦片类疼痛治疗市场的成长。老年人口不断增加，更容易患关节炎和其他关节疾病，癌症和相关疼痛的高发病率，以及推动新疗法研究和开发的有利监管环境等因素预计将增加对非阿片类药物的需求。然而，一旦主要品牌的专利到期，仿製药替代品的可用性等因素可能会阻碍老牌企业的收入成长。

市场动态：

全球非鸦片类疼痛治疗市场的成长是由以下因素推动的：人们对长期使用鸦片类药物、重复性压力损伤和其他与工作相关的肌肉骨骼疾病的风险认识不断提高，以及止痛药物开发商和医疗器材公司之间的策略合作不断加强。然而，新型药物输送系统的开发成本较高，且与鸦片类药物相比疗效较低，可能会阻碍市场成长。人们越来越关注先进药物配方、联合疗法和神经刺激设备的开发，为该行业的主要参与者提供了利润丰厚的机会。

研究的主要特点：

该报告对全球非鸦片类疼痛治疗市场进行了深入分析，并提供了预测期（2024-2031）的市场规模和年复合成长率（CAGR%），以2023年为基准年。
它阐明了不同细分市场的潜在收入成长机会，并解释了该市场有吸引力的投资主张矩阵。
这项研究还提供了有关市场驱动因素、限制因素、机会、新产品发布或批准、市场趋势、区域前景以及主要参与者采取的竞争策略的重要见解。
它根据以下参数（例如公司亮点、产品组合、主要亮点、财务表现和策略）介绍了全球非鸦片类疼痛治疗市场的主要参与者。
本研究涵盖的主要公司包括辉瑞公司、梯瓦製药工业有限公司、Dr. Reddy's Laboratories Ltd.、Sun Pharmaceutical Industries Ltd.、Cipla Inc.、Fresenius Kabi AG、GSK、Vertex Pharmaceuticals Incorporated、Pacira BioSciences 、legium Pharmaceuticals、 Cara Therapeutics、Akelos、Fidia Farmaceutici SpA、赛诺菲、礼来公司、默克公司和Acorda Therapeutics。
该报告的见解将使行销人员和公司管理当局能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
全球非阿片类疼痛治疗市场报告迎合了该行业的各个利益相关者，包括投资者、供应商、产品製造商、分销商、新进业者和财务分析师。
利害关係人可以透过用于分析全球非鸦片类疼痛治疗市场的各种策略矩阵轻鬆做出决策。

介绍
北美洲
我们
加拿大
欧洲
英国
德国
义大利
法国
西班牙
俄罗斯
欧洲其他地区
亚太地区
中国
印度
日本
澳洲
韩国
东协
亚太其他地区
拉丁美洲
巴西
墨西哥
阿根廷
拉丁美洲其他地区
中东
海湾合作委员会
以色列
中东其他地区
非洲
南非
北非
中非

第 9 章：公司简介 - 全球非鸦片类疼痛治疗市场

Pfizer Inc.
- 公司简介
- 产品/服务组合
- 财务绩效
- 最新动态/更新
- 战略概览
Teva Pharmaceutical Industries Ltd.
Dr. Reddy's Laboratories Ltd.
Sun Pharmaceutical Industries Ltd.
Cipla Inc.
Fresenius Kabi AG
GSK
Vertex Pharmaceuticals Incorporated
Pacira BioSciences
Collegium Pharmaceuticals
Cara Therapeutics
Akelos
Fidia Farmaceutici SpA
Sanofi
Eli Lilly and Company
Merck & Co
Acorda Therapeutics
Hyloris Pharmaceuticals
Hikma Pharmaceuticals PLC

第 10 章：参考文献与研究方法

参考
研究方法论

简介目录

Product Code: CMI6741

Global non opioid pain treatment market is estimated to be valued at USD 78.89 billion in 2024 and is expected to reach USD 140.56 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.6% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2023/2024:	US$ 78.89 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2023/2024 to 2030/2031 CAGR:	8.60%	2030/2031 Value Projection:	US$ 140.56 Bn

Global Non Opioid Pain Treatment Market Share (%), By Region, 2024

Global Non Opioid Pain Treatment Market - IMG1

Rising prevalence of chronic pain disorders and increasing focus toward developing safer alternatives to opioid analgesics are driving the global non opioid pain treatment market growth. Factors such as growing geriatric population who are more prone to arthritis and other joint disorders, high incidence of cancer and associated pain, and favorable regulatory environment providing a push to research and development of novel therapies are expected to boost demand for non opioid medications. However, factors such as the availability of generic substitutes once patents of major brands expire can hamper the revenue growth of established players.

Market Dynamics:

Global non opioid pain treatment market growth is driven by factors such as growing awareness about risks of long term opioid usage, repetitive stress injuries and rising other work related musculoskeletal disorders, and increasing strategic collaborations between pain drug developers and medical device companies. However, high development cost of novel drug delivery systems and perceived lower efficacy as compared to opioids can hamper the market growth. Growing focus on development of advanced drug formulations, combination therapies, and neurostimulation devices present lucrative opportunities for major players in this industry.

Key Features of the Study:

This report provides an in-depth analysis of the global non opioid pain treatment market, and provides market size (US$ Billion) and compound annual growth rate (CAGR %) for the forecast period (2024-2031), considering 2023 as the base year.
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global non opioid pain treatment market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
The key companies covered as a part of this study include Pfizer Inc., Teva Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Cipla Inc., Fresenius Kabi AG, GSK, Vertex Pharmaceuticals Incorporated, Pacira BioSciences, Collegium Pharmaceuticals, Cara Therapeutics, Akelos, Fidia Farmaceutici S.p.A., Sanofi, Eli Lilly and Company, Merck & Co, and Acorda Therapeutics.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global non opioid pain treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global non opioid pain treatment market.

Detailed Segmentation:

Drug Type:
- Non-Steroidal Anti-Inflammatory Drugs
- Steriods
- Analgesics
- Corticosteroids
- Others
Indication:
- Musco Skeletal Disorders
- Central Nervous System Disorders
- Traumatic Pain
- Chronic Pain
- Others
Distribution Channel:
- Online Pharmacies
- Retail Pharmacies
- Hospital Pharmacies
Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Pfizer Inc.
- Teva Pharmaceutical Industries Ltd.
- Reddy's Laboratories Ltd.
- Sun Pharmaceutical Industries Ltd.
- Cipla Inc.
- Fresenius Kabi AG
- GSK
- Vertex Pharmaceuticals Incorporated
- Pacira BioSciences
- Collegium Pharmaceuticals
- Cara Therapeutics
- Akelos
- Fidia Farmaceutici S.p.A.
- Sanofi
- Eli Lilly and Company
- Merck & Co
- Acorda Therapeutics

1. Research Objectives and Assumptions

Research Objectives
Assumptions

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot By Drug Type
- Market Snapshot By Indication
- Market Snapshot By Route of Administration
- Market Snapshot By Distribution Channel
- Market Snapshot By Region
- Market Scenario - Conservative, Like, Opportunistic
Market Opportunity Map

3. Key Insights

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Pest Analysis
Porters Analysis
Technological Advancement
Merger, Acquisition and Collaboration Scenario
Recent Product Approvals
Company Market Share Analysis
Regulatory Scenario
Pricing Analysis
COVID-19 Impact Analysis
Route of Administration Analysis
Reimbursement Scenario

4. Global Non Opioid Pain Treatment Market, By Drug Type, 2019 - 2031 (US$ Billion)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031
- Market Y-o-Y Growth Comparison (%), 2019 - 2031
- Segment Trends
Non-Steroidal Anti-Inflammatory Drugs, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Steriods, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Analgesics , 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Corticosteroids, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Others, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)

5. Global Non Opioid Pain Treatment Market, By Indication, 2019 - 2031 (US$ Billion)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031
- Market Y-o-Y Growth Comparison (%), 2019 - 2031
- Segment Trends
Musco Skeletal Disorders, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Central Nervous System Disorders, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Traumatic Pain, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Chronic Pain, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Others, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)

6. Global Non Opioid Pain Treatment Market, By Route of Administration, 2019 - 2031 (US$ Billion)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031
- Market Y-o-Y Growth Comparison (%), 2019 - 2031
- Segment Trends
Topical, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Intravenous, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Oral, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)

7. Global Non Opioid Pain Treatment Market, By Distribution Channel, 2019 - 2031 (US$ Billion)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031
- Market Y-o-Y Growth Comparison (%), 2019 - 2031
- Segment Trends
Online Pharmacies, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Retail Pharmacies, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Hospital Pharmacies, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)

8. Global Non Opioid Pain Treatment Market, By Region, 2019 - 2031 (US$ Billion)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031, (US$ Billion)
- Market Y-o-Y Growth Comparison (%), 2019 - 2031, (US$ Billion)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Drug Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Indication, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, By Drug Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Indication, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
U.K.
Germany
Italy
France
Spain
Russia
Rest Of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Drug Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Indication, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
China
India
Japan
Australia
South Korea
Asean
Rest Of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, By Drug Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Indication, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
Brazil
Mexico
Argentina
Rest Of Latin America
Middle East
- Introduction
- Market Size and Forecast, By Drug Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Indication, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
GCC
Israel
Rest Of The Middle East
Africa
- Introduction
- Market Size and Forecast, By Drug Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Indication, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
South Africa
North Africa
Central Africa

9. Company Profiles - Global Non Opioid Pain Treatment Market

Pfizer Inc.
- Company Overview
- Product/Service Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategic Overview
Teva Pharmaceutical Industries Ltd.
Dr. Reddy's Laboratories Ltd.
Sun Pharmaceutical Industries Ltd.
Cipla Inc.
Fresenius Kabi AG
GSK
Vertex Pharmaceuticals Incorporated
Pacira BioSciences
Collegium Pharmaceuticals
Cara Therapeutics
Akelos
Fidia Farmaceutici S.p.A.
Sanofi
Eli Lilly and Company
Merck & Co
Acorda Therapeutics
Hyloris Pharmaceuticals
Hikma Pharmaceuticals PLC